BLMH
Price
$0.73
Change
-$0.14 (-16.09%)
Updated
May 21 closing price
Capitalization
N/A
ESALF
Price
$27.00
Change
+$1.00 (+3.85%)
Updated
May 21 closing price
Capitalization
18.29B
Interact to see
Advertisement

BLMH vs ESALF

Header iconBLMH vs ESALF Comparison
Open Charts BLMH vs ESALFBanner chart's image
Blum Holdings
Price$0.73
Change-$0.14 (-16.09%)
Volume$9.43K
CapitalizationN/A
Eisai
Price$27.00
Change+$1.00 (+3.85%)
Volume$1.75K
Capitalization18.29B
BLMH vs ESALF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BLMH vs. ESALF commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLMH is a Hold and ESALF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (ESALF: $27.00)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 1 FA rating(s) are green while.

  • ESALF’s FA Score: 1 green, 4 red.

Price Growth

ESALF (@Pharmaceuticals: Other) experienced а +3.85% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.10%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +30.06%.

Industries' Descriptions

@Pharmaceuticals: Other (-0.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
BLMH YTD gains are higher at: 64.045 vs. ESALF (5.099).
BLMHESALFBLMH / ESALF
CapitalizationN/A18.3B-
EBITDAN/A87.3B-
Gain YTD64.0455.0991,256%
P/E RatioN/A46.30-
RevenueN/A744B-
Total CashN/A268B-
Total DebtN/A126B-
FUNDAMENTALS RATINGS
BLMH vs ESALF: Fundamental Ratings
BLMH
ESALF
OUTLOOK RATING
1..100
1231
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3558
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (9) in the null industry is in the same range as BLMH (36). This means that ESALF’s stock grew similarly to BLMH’s over the last 12 months.

ESALF's Profit vs Risk Rating (100) in the null industry is in the same range as BLMH (100). This means that ESALF’s stock grew similarly to BLMH’s over the last 12 months.

ESALF's SMR Rating (100) in the null industry is in the same range as BLMH (100). This means that ESALF’s stock grew similarly to BLMH’s over the last 12 months.

BLMH's Price Growth Rating (35) in the null industry is in the same range as ESALF (58). This means that BLMH’s stock grew similarly to ESALF’s over the last 12 months.

ESALF's P/E Growth Rating (93) in the null industry is in the same range as BLMH (100). This means that ESALF’s stock grew similarly to BLMH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFVNX12.22N/A
N/A
MassMutual Equity Opports R3
HMVYX17.56N/A
N/A
Hartford MidCap Value Y
JSERX52.85N/A
N/A
JPMorgan Small Cap Equity R5
BRTNX74.52N/A
N/A
Bretton Fund
NPFFX65.37-0.75
-1.13%
American Funds New Perspective F1

BLMH and

Correlation & Price change

A.I.dvisor tells us that BLMH and CVSI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLMH and CVSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLMH
1D Price
Change %
BLMH100%
-16.43%
CVSI - BLMH
22%
Poorly correlated
-6.47%
ESALF - BLMH
21%
Poorly correlated
+3.85%
CTTH - BLMH
21%
Poorly correlated
+3.15%
VEXTF - BLMH
21%
Poorly correlated
-3.27%
SDZXF - BLMH
5%
Poorly correlated
+2.57%
More

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
+3.85%
ESAIY - ESALF
26%
Poorly correlated
+2.87%
DVAX - ESALF
23%
Poorly correlated
-4.99%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
-7.23%
BLMH - ESALF
21%
Poorly correlated
-16.43%
More